Yecuris FRG: humanized animals and human hepatocytes platform for your next great discovery.
  • SCHEDULE A MEETING
  • FRG® PLATFORM
    • Platform Overview
    • FRG® KO Mice
    • Fresh Hepatocytes
    • Reagents
  • APPLICATION AREAS
    • Gene & Cell Therapy
    • NASH
    • Infectious Disease
    • DMPK
    • Custom Transplantation
  • RESEARCH SERVICES
  • COMPANY
    • Upcoming Events
    • About Us
    • Publications
    • Contact Us
    • Careers
Select Page
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice.

Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice.

by CBartell | Feb 11, 2019 | Publications

Abstract Mice that could be highly repopulated with human hepatocytes would have many potential uses in drug development and research applications. The best available model of liver humanization, the uroplasminogen-activator transgenic model, has major practical...

Recent Posts

  • Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice.
  • Seattle BioMed and Yecuris Team Up to Identify Novel Vaccine and Drug Candidates for Malaria
  • Taconic and Yecuris Corporation Announce Strategic Marketing Alliance

Recent Comments

    Archives

    • February 2019
    • June 2014
    • February 2013

    Categories

    • Press Releases
    • Publications

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    FRG® PLATFORM

    FRG® KO Mice

    Fresh Hepatocytes

    Reagents

    APPLICATION AREAS

    Gene & Cell Therapy

    Infectious Disease

    NASH

    DMPK

    YECURIS

    Research Services

    About Us

    Publications

    Contact Us

    FRG® KO UPDATES

    • Facebook
    • Twitter
    Yecuris Corporation | P.O. Box 4645, Tualatin, OR 97062 | 503.352.4663     Privacy Policy    Terms & Conditions
    ©2018 Yecuris Corporation. All rights reserved. Yecuris™, FRG®, MetAbArray™, HepaCur™ and CuRx™ are trademarks of Yecuris Corporation.